Scientists develop novel vaccine for Lassa fever and rabies
A novel vaccine designed to protect people from both Lassa fever and rabies showed promise in preclinical testing, according to new research published in Nature Communications. The inactivated recombinant vaccine candidate uses a weakened rabies virus vector, or carrier. October 11, 2018